Nanoparticles for immunotherapy

Details for Australian Patent Application No. 2009285628 (hide)

Owner Ecole Polytechnique Federale De Lausanne

Inventors Hubbell, Jeffrey A.; O'Neil, Conlin P.; Reddy, Sai T.; Swartz, Melody A.; Velluto, Diana; Van Der Vlies, Andre; Simeoni, Eleonora

Agent Griffith Hack

Pub. Number AU-A-2009285628

PCT Pub. Number WO2010/025324

Priority 12/231,310 29.08.08 US

Filing date 28 August 2009

Wipo publication date 4 March 2010

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

24 March 2011 PCT application entered the National Phase

  PCT publication WO2010/025324 Priority application(s): WO2010/025324

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009285632-Compositions and methods of treatment comprising ceftaroline

2009285625-Method for treating multiple sclerosis patients with anti-IL2R antibodies